Loading...
Dear Readers,
This past year has seen the publication of many high-quality research studies informing the practice of gastroenterology and hepatology. Here are the highlights as I see them, as reflected in the NEJM Journal Watch Gastroenterology top stories of 2018, listed below.
In the treatment of liver diseases, therapies for hepatitis C and hepatitis B are being optimized, and there is now evidence that direct-acting antiviral drugs improve survival in patients with hepatitis C. We may be seeing the end of continually changing recommendations for hepatitis C treatment.
There is good news in the treatment of Barrett esophagus: High-dose proton-pump inhibitor (PPI) therapy combined with aspirin seems to decrease its progression. For esophage…